Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT01502904
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT01502904
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01502904. Randomized; single masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2015-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents
- Condition
- Stable Angina or Acute Coronary Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension
- Intervention (Device)
- Sirolimus-eluting stent
- Intervention (Device)
- Biolimus-eluting stents
- Intervention (Drug)
- pravastatin 20mg/day after DES implantation
- Intervention (Drug)
- pitavastatin 2mg/day after DES implantation
- Intervention (Drug)
- Non-ARB /day after DES implantation
- Intervention (Drug)
- Eposartan 600mg/day after DES implantation
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct01502904- Content hash
33fabcd8dc61fe42ee61698594e030db95063c9949426f47c97aa48c65df903e